FDA approved KERENDIA (finerenone) as the first new treatment in 30 years for adults with chronic kidney disease associated ...

Vera Therapeutics, Inc. ( VERA) reported that in the pivotal ORIGIN 3 trial of TRUTAKNA (atacicept-vymj), an FDA-approved dual BAFF and APRIL inhibitor, it stabilised kidney function and prevented ...

Deals: Apollo Global Management is in negotiations to acquire Johnson & Johnson’s DePuy Synthes orthopedics business in a ...

As one notable company exits the field, growing CDMOs open facilities and secure major contracts ...

the curiosity to learn, the willingness to adapt, the courage to be uncomfortable, and the commitment to solve real human problems will define the true technology change-makers ...

Studies show shingles vaccines may lower dementia risk by 20%. Vaccinologist Helen Petousis-Harris explains what this means for NZ.

The strongest evidence so far comes from studies of Shingrix. A 2024 study in Nature Medicine found people who received ...

One problem with following innovation is that the extraordinary now arrives disguised as the weekly. A frontier model trained ...

BrainChild Bio has raised a $116 million Series A financing, the proceeds of which will, in part, fund the pivotal ...

Officials from the US met Iran-backed, Yemen-based Houthi rebel leaders over the weekend in Oman, which led to Washington's ...

A shingles vaccine used routinely in older adults is being linked to a significantly lower risk of dementia, according to a large new study led by Brown University researchers. The study, published in ...